参考文献 1 徐小元 、 丁惠国 、 李文刚 、 贾继东 、 魏 来 、 段钟平 、 令狐恩强 、 庄辉 。 肝硬化腹 水及相关并发症的诊疗指南 [ J ] 。 中华实 验和临床感染病杂志 ( 电子版 ), 2017 , 11 ( 05 ): 417-432 。 2 Biggins SW et al ; AASLD . Diagnosis , evaluation , and management of ascites and hepatorenal syndrome . Hepatology 2021 ; doi : 10.1002 / hep . 31884 . 3 European Association for the Study of the Liver . EASL clinical practice guidelines on the management of ascites , spontaneous bacterial peritonitis , and hepatorenal syndrome in cirrhosis . J Hepatol 2010 ; 53 ( 3 ): 397 – 417 . 4 Aithal GP et al . Guidelines on the management of ascites in cirrhosis . Gut 2021 ; 70 ( 1 ): 9 – 29 . 5 Angeli P et al . Diagnosis |
and management of acute kidney injury in patients with cirrhosis : revised consensus recommendations of the International Club of Ascites [ published correction appears in J Hepatol . 2015 Jul ; 63 ( 1 ): 290 ]. J Hepatol 2015 ; 62 ( 4 ): 968 – 74 . 6 Arora V et al . Paracentesisinduced circulatory dysfunction with modestvolume paracentesis is partly ameliorated by albumin infusion in acute-on-chronic liver failure . Hepatology 2020 ; 72 ( 3 ): 1043 – 55 . 7 Sen Sarma M et al . Safety , complications and outcome of large volume paracentesis with or without albumin therapy in children with severe ascites due to liver disease . J Hepatol 2015 ; 63 ( 5 ): 1126 – 32 . 8 Fernández J et al . Effects of albumin treatment on systemic |
and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis . Gastroenterology 2019 ; 157 ( 1 ): 149 – 62 . 9 Caraceni P et al . Long-term albumin administration in decompensated cirrhosis ( ANSWER ): an open-label randomised trial [ published correction appears in Lancet . 2018 Aug 4 ; 392 ( 10145 ): 386 ]. Lancet 2018 ; 391 ( 10138 ): 2417 – 29 . 10 China L et al . A randomized trial of albumin infusions in hospitalized patients with cirrhosis . N Engl J Med 2021 ; 384 ( 9 ): 808 – 17 . 11 Salerno F , Navickis RJ , Wilkes MM . Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis : a meta-analysis of randomized trials . Clin Gastroenterol Hepatol |
2013 ; 11 ( 2 ): 123 – 30 . 12 Thévenot T et al . Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis . A randomized trial . J Hepatol 2015 ; 62 ( 4 ): 822 – 30 . 13 Wong F et al . Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome . N Engl J Med 2021 ; 384 ( 9 ): 818 – 28 . 14 Gentilini P et al . Albumin improves the response to diuretics in patients with cirrhosis and ascites : results of a randomized , controlled trial . J Hepatol 1999 ; 30 ( 4 ): 639 – 45 . 15 Romanelli RG et al . Longterm albumin infusion improves survival in patients with cirrhosis and ascites : an unblinded randomized trial . World J Gastroenterol 2006 ; 12 ( 9 ): 1403 – 7 . 16 Di Pascoli M et al . Long-term |
administration of human albumin improves survival in patients with cirrhosis and refractory ascites . Liver Int 2019 ; 39 ( 1 ): 98 – 105 . 17 Bureau C et al . Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites [ published correction appears in Gastroenterology 2017 ; 153 ( 3 ): 870 ]. Gastroenterology 2017 ; 152 ( 1 ): 157 – 63 . 18 Bernardi M , Caraceni P . Novel perspectives in the management of decompensated cirrhosis . Nat Rev Gastroenterol Hepatol 2018 ; 15 ( 12 ): 753 – 64 .. |